Status:
COMPLETED
Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Biliary Atresia
Eligibility:
All Genders
4-3 years
Phase:
NA
Brief Summary
Abstract Biliary atresia (BA) is an idiopathic, progressive, and fatal disease if untreated. Since Kasai first introduced the operation for BA in 1959, there have been encouraging results in treating...
Detailed Description
Biliary atresia (BA) is an idiopathic, progressive, and fatal disease if untreated. Since Kasai first introduced the operation for BA in 1959, there have been encouraging results in treating this dise...
Eligibility Criteria
Inclusion
- Biliary atresia patients aged 0 to 3 years, who had a Kasai operation
Exclusion
- The patients who had received liver transplantation
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00166868
Start Date
December 1 2003
End Date
July 1 2012
Last Update
August 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan